Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2016 Oct;101(10):3564-3567.
doi: 10.1210/jc.2016-2051. Epub 2016 Sep 1.

Pancreatic Neuroendocrine Tumor Secreting Vasoactive Intestinal Peptide and Dopamine With Pulmonary Emboli: A Case Report

Affiliations
Case Reports

Pancreatic Neuroendocrine Tumor Secreting Vasoactive Intestinal Peptide and Dopamine With Pulmonary Emboli: A Case Report

Naris Nilubol et al. J Clin Endocrinol Metab. 2016 Oct.

Abstract

Context: The vasoactive intestinal peptide-secreting neuroendocrine tumor (VIPoma) is a very rare pancreatic tumor. We report the first case of a patient with VIPoma that co-secreted dopamine and had pulmonary emboli.

Case description: A 67-year-old woman presented with 2 months of watery diarrhea, severe generalized weakness,6.8 kg of weight loss, a facial rash, and hypokalemia. Colonoscopy did not reveal the cause of the chronic diarrhea. Initial biochemical testing showed markedly elevated serum vasoactive intestinal peptide (VIP) and pancreatic polypeptide. Computed tomography scan of the abdomen and pelvis revealed a 5.4-cm distal pancreatic mass. Octreoscan showed an intense uptake in the area of the pancreatic mass. Incidental pulmonary emboli were found and treated. Additional biochemical testing revealed a markedly elevated urinary dopamine level. The patient received preoperative α-blockade and octreotide. She underwent a successful laparoscopic distal pancreatectomy. Postoperative urinary dopamine and pancreatic polypeptide were within normal limits. Serum VIP decreased by half but remained elevated. Pathology confirmed a grade 1 pancreatic neuroendocrine tumor without lymph node metastasis. The patient's symptoms resolved and no longer required octreotide. Metastatic workup including computed tomography, F18-fluorodeoxglucose positron emission tomography, and Ga68-DOTATATE scans were negative during 4 years of follow-up.

Conclusions: VIPoma is a rare subtype of pancreatic neuroendocrine tumor that can secrete dopamine and can be associated with thromboembolism.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Radiographic imaging of a patient with VIPoma. A, Contrast-enhanced CT scan of the abdomen showed pancreatic tail mass (blue arrow). B, A pulmonary CT angiography showed right segmental pulmonary artery-filling defects. C, Octreoscan. D, F18-FDG PET/CT scan showed an intense uptake in the pancreatic tail mass.
Figure 2.
Figure 2.
Histology of PNET secreting VIP and dopamine. A, Hematoxylin and eosin staining; B, synaptophysin; C, chromogranin; and D, pancreatic polypeptide immunohistochemistry.
Figure 3.
Figure 3.
VIP expression in the adjacent normal pancreas (A) and in the PNET (B). DOPA-decarboxylase expression in the adjacent normal pancreas (C) and in the PNET (D).

References

    1. Halfdanarson TR, Rubin J, Farnell MB, Grant CS, Petersen GM. Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors. Endocr Relat Cancer. 2008;15:409–427. - PMC - PubMed
    1. Ghaferi AA, Chojnacki KA, Long WD, Cameron JL, Yeo CJ. Pancreatic VIPomas: subject review and one institutional experience. J Gastrointest Surg. 2008;12:382–393. - PubMed
    1. Bani Sacchi T, Bani D, Biliotti G. Are pancreatic VIPomas paraneuron neoplasms? A clue to the neuroectodermal origin of these tumors. Pancreas. 1992;7:87–97. - PubMed
    1. Chen YF, Liu TH, Chen SP, et al. Watery diarrhea syndrome caused by multihormonal malignant pancreatic islet cell tumor secreting somatostatin, vasoactive intestinal peptide, serotonin, and prostaglandin E–a clinicopathological, biochemical, immunohistochemical, and ultrastructural study. Pancreas. 1986;1:80–89. - PubMed
    1. Ciofu A, Baudin E, Chanson P, et al. Catecholamine production in patients with gastroenteropancreatic neuroendocrine tumors. Eur J Endocrinol. 1999;140:434–437. - PubMed

Publication types